Searched for
BHARAT BIOTECH S COVAXIN
No impact on efficacy and safety of Covaxin: Bharat Biotech after WHO suspension"For the millions who have received COVAXIN, the vaccine certificates issued still stand valid as there is no impact on efficacy and safety...- WHO suspends UN supply of Bharat Biotech's Covaxin citing 'deficiencies'The WHO asked countries that have received the vaccine to take appropriate actions, according to the statement, but did not specify what th...
- Covaxin to be evaluated as COVID-19 vaccine candidate in US: Bharat BiotechCovaxin has already been granted Emergency Use Listing (EUL) in 13 countries as on January 31 according to the WHO. Covaxin was granted EUL...
- Bharat Biotech’s Covaxin took less time for EUL than several other vaccines: WHO“WHO has a technical advisory group made up of independent experts who assess COVID19 vaccines. The process relies on manufacturers to prov...
- Covaxin gets WHO approval for emergency use listingWHO's TAG is an independent advisory group that provides recommendations to the WHO on whether a Covid 19 vaccine can be listed for emergen...
- Bharat Biotech's Covaxin gets WHO okay for emergency useHyderabad-based Bharat Biotech, which has developed Covaxin, submitted EOI (Expression of Interest) to the WHO on April 19 for the vaccine'...
- WHO seeks 'additional clarifications' from Bharat Biotech for Covaxin to conduct final 'risk-benefit assessment'"The TAG met today (26 October 2021) and decided that additional clarifications from the manufacturer are needed to conduct a final EUL ris...
- WHO advisory group to meet on Oct 26 to decide on Bharat Biotech’s CovaxinWHO had earlier said that Bharat Biotech has been submitting data to it on a rolling basis and had submitted additional information on 27 S...
- Decision on Bharat Biotech's Covaxin EUL in October, says WHOThe latest 'Status of COVID-19 vaccines within WHO EUL/PQ evaluation process' guidance document dated September 29 on the WHO website said ...
- WHO's emergency use authorisation for Covaxin further delayed: SourcesThe sources further said that the UN public health agency has asked for more data from Bharat Biotech for Covaxin. This delay will affect I...
- Covaxin receives GMP certificate from Hungary: Bharat BiotechBharat Biotech intends to submit documentation for emergency use authorisation to several additional countries worldwide, the company said.
- Brazil suspends clinical trials of Bharat Biotech's Covaxin“The Coordination of Clinical Research at Anvisa (Copec/GGMED) determined this Friday (23/7) the precautionary suspension of clinical studi...
- Bharat Biotech ties up with Ocugen to commercialise Covaxin in CanadaUnder the agreement, Ocugen will have the US rights to the vaccine candidate and will be responsible for clinical development, regulatory a...
- New Delhi now engages in quiet Covaxin diplomacyUnlike China, India is not pursuing an aggressive policy to get Covaxin approved but rather a quiet diplomacy, advising Bharat Biotech on n...
- Bharat Biotech claims 77.8% efficacy of Covaxin in phase-3 trialsAnnouncing the much awaited safety and efficacy data from phase-3 clinical trials of Covaxin, the IMCR director Prof Balram Bhargava said C...
- Bharat Biotech’s Covaxin supply falls short of government ordersAccording to the Centre's affidavit, over 1.8 million doses of Covaxin are pending against its order for 20 million doses in March.
- Ocugen pays $15 mn upfront to Bharat Biotech for Covaxin rights in CanadaThe Indian biotech company and Ocugen Inc have entered into a definitive agreement to co-develop, supply, and commercialise Covaxin for the...
- Timeline: How India's coronavirus vaccine got approved by drugs expertsCOVAXIN has been developed by Bharat Biotech, a company based in Hyderabad, with backing from the state-run Indian Council of Medical Resea...
- After Haryana's Anil Vij tests positive, Bharat Biotech says COVAXIN efficacious, safe"COVAXIN clinical trials are based on a two-dose schedule, given 28 days apart. The vaccine efficacy will be determined 14 days after the s...
- Bharat Biotech begins Phase-III trials for COVID-19 vaccine, Covaxin, with 26,000 volunteers"This is India's first phase-III efficacy study for a Covid-19 vaccine, and the largest phase-III efficacy trial ever conducted in India," ...
Load More
